尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Kalayoglu Murat. Director active across 1 company, notably Cartesian Therapeutics, Inc.. Aggregated, 7 disclosures have been published. Activity tracked since 13 November 2023. The latest transaction was filed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Kalayoglu Murat is a declarant linked to Cartesian Therapeutics, Inc., where he is listed as a 10% Owner. The record shows 7 filings in total, and the sampled recent filings cover the period from 2023-11-15 to 2026-04-06, with the transaction nature shown as Attribution.